Leaflet TETANUS GAMMA 250UI/1ml 250UI / ml solution for injection in pre-filled syringe


Indicated for: prevention of tetanus

Route of administration: injectable

Substance: human anti-tetanus immunoglobulin (immunoglobulin)

ATC: J06BB02 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Human anti-tetanus immunoglobulin is used for the prevention of tetanus in patients with contaminated wounds or those who have not been properly vaccinated. It contains specific antibodies against the tetanus toxin, providing immediate protection.

The medication is administered intramuscularly, as directed by a doctor. It is important to administer it as soon as possible after exposure.

Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.

Human anti-tetanus immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about TETANUS GAMMA 250UI/1ml 250UI / ml

  • Substance: human anti-tetanus immunoglobulin
  • Date of last drug list: 01-05-2026
  • Commercial code: W70454001
  • Concentration: 250UI / ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 1
  • Product type: generic
  • Price: 115.37 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: KEDRION S.P.A. - ITALIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 938/2024/01
  • Shelf life: 3 years